Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Cryptos to Watch as the Blockchain Fights the Fed

By Josh Enomoto, InvestorPlace Contributor

Although optimism typically rings high for cryptos, participating investors must also recognize broader economic realities.

Why Is Qualcomm (QCOM) Stock Falling 4% Today?

By Josh Enomoto, InvestorPlace Contributor

Qualcomm took government restrictions against China-focused exports on the chin due to overexposure, thus hurting QCOM stock.

Smart Investors Will Be Buying All the Dips for These 7 Stocks

By Josh Enomoto, InvestorPlace Contributor

Although the red ink has many investors shook on Wall Street, it also enticingly opens the floodgates for these 7 stocks to buy on the dip.

Merck (MRK) Stock Jumps 4% on Positive Trial Data

By Josh Enomoto, InvestorPlace Contributor

Merck took a big gamble in buying a therapeutic as part of an acquisition deal and it appears to have paid off, sending MRK stock soaring.

7 Energy Stocks to Buy on the Historic OPEC Production Cuts

By Josh Enomoto, InvestorPlace Contributor

With global oil supplies likely to take a hit because of the OPEC+ cuts, investors should consider these energy stocks to buy.

Netflix (NFLX) Stock Rises on High Expectations for Ad Sales

By Josh Enomoto, InvestorPlace Contributor

With Netflix reeling this year, many analysts see its pivot to ad-tier subs as positive for NFLX stock though not all are convinced.

7 Value Stocks That Are Too Cheap to Ignore

By Josh Enomoto, InvestorPlace Contributor

With market and economic forces eschewing growth-focused companies, now may be the time to consider cheap value stocks to buy.

Levi Strauss (LEVI) Stock Sinks 10% on Reduced Guidance

By Josh Enomoto, InvestorPlace Contributor

Although Levi Strauss admitted to macro pressures forcing a full-year downgrade, LEVI stock might perform better than its peers.

CVS Health (CVS) Stock Falls 10% on Health Insurance Plan Downgrade

By Josh Enomoto, InvestorPlace Contributor

CVS Health received an insurance-related downgrade from Medicare, sending CVS stock into the dumps despite management’s reassurances.

7 Small-Cap Stocks That Are Too Cheap to Ignore

By Josh Enomoto, InvestorPlace Contributor

Although this avenue is best reserved for contrarian speculators, some exciting opportunities exist among cheap small-cap stocks to buy.

Load More